Related Experiment Video
Updated: May 5, 2026
08:30
A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
Published on: February 14, 2022
2.6K
[Alternative treatments to heart transplant]
Anales De La Real Academia Nacional De Medicina
|December 5, 2013
Insights
Advances in heart failure treatments, including medical, devices, and surgical interventions, have reduced the necessity of heart transplantation. These evolving therapies are increasingly limiting the role of heart transplantation as a primary treatment option.
Area of Science:
- Cardiology and Cardiovascular Surgery
- Medical Device Technology
- Interventional Cardiology
Background:
- Significant advancements in heart failure (HF) management over the last four decades.
- Development and integration of novel medical therapies, electrical devices, and surgical techniques.
- Evolution of percutaneous revascularization and circulatory support systems.
Discussion:
- Heart transplantation is no longer the sole essential treatment for end-stage heart failure.
- The expanding armamentarium of HF therapies is progressively diminishing the primary role of transplantation.
- Comparative analysis of outcomes and indications for various advanced HF treatments.
Key Insights:
- Medical and interventional treatments have significantly improved heart failure outcomes.
- Electrical devices and surgical interventions offer viable alternatives to transplantation.
- The landscape of heart failure treatment is shifting towards less invasive and more accessible options.
Outlook:
- Continued innovation in non-transplant-based heart failure therapies.
- Potential for further reduction in heart transplant indications.
- Focus on personalized medicine and device integration for heart failure management.
Abstract:
On the past 40 years it has been a significant advance in the Heart Failure treatment, both medical and electrical devices, percutaneous revascularization, surgery, and circulatory support. With them heart transplantation is no longer an essential treatment. Gradually the other techniques are limiting the role of heart transplantation in the final treatment of Heart Failure.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
01:29Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
01:30Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
01:28Kidney Transplant I: Introduction
827
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
827
01:30Heart Failure V: Medical Management
626
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626
01:24Tissue Transplantation
1.4K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K